Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All"in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/μL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.
CITATION STYLE
Nasuuna, E., Tenforde, M. W., Muganzi, A., Jarvis, J. N., Manabe, Y. C., & Kigozi, J. (2020). Reduction in Baseline CD4 Count Testing following Human Immunodeficiency Virus “treat All” Adoption in Uganda. Clinical Infectious Diseases, 71(9), 2497–2499. https://doi.org/10.1093/cid/ciaa261
Mendeley helps you to discover research relevant for your work.